Li RM - Search Results

1

Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome.

Zheng YW, Li RM, Zhang XW, Ren XB. Zheng YW, et al. Among authors: li rm. Cancer Invest. 2013 Mar;31(3):197-205. doi: 10.3109/07357907.2013.775294. Cancer Invest. 2013. PMID: 23477587 Review.

2

IDO inhibits T-cell function through suppressing Vav1 expression and activation.

Li R, Wei F, Yu J, Li H, Ren X, Hao X. Li R, et al. Cancer Biol Ther. 2009 Jul;8(14):1402-8. doi: 10.4161/cbt.8.14.8882. Epub 2009 Jul 30. Cancer Biol Ther. 2009. PMID: 19597340 Free article.

3

[Expression of indoleamine 2, 3-dioxygenase and its correlation with prognosis in breast cancer patients].

Liu JT, Wei LJ, Yu JP, Li H, Li RM, Zang FL, Sun JY, Ren XB. Liu JT, et al. Among authors: li h, li rm. Zhonghua Zhong Liu Za Zhi. 2011 Jul;33(7):513-6. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22093628 Chinese.

4

How do tumor stem cells actively escape from host immunosurveillance?

Qi Y, Li RM, Kong FM, Li H, Yu JP, Ren XB. Qi Y, et al. Among authors: li h, li rm. Biochem Biophys Res Commun. 2012 Apr 20;420(4):699-703. doi: 10.1016/j.bbrc.2012.03.086. Epub 2012 Mar 23. Biochem Biophys Res Commun. 2012. PMID: 22465008 Review.

5

Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.

Li R, Wang C, Liu L, Du C, Cao S, Yu J, Wang SE, Hao X, Ren X, Li H. Li R, et al. Cancer Immunol Immunother. 2012 Nov;61(11):2125-33. doi: 10.1007/s00262-012-1260-2. Epub 2012 May 13. Cancer Immunol Immunother. 2012. PMID: 22581306 Free PMC article. Clinical Trial.

6

Primary hepatic angiosarcoma and potential treatment options.

Zheng YW, Zhang XW, Zhang JL, Hui ZZ, Du WJ, Li RM, Ren XB. Zheng YW, et al. Among authors: li rm. J Gastroenterol Hepatol. 2014 May;29(5):906-11. doi: 10.1111/jgh.12506. J Gastroenterol Hepatol. 2014. PMID: 24372769 Review.

7

Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells.

Hui Z, Zhang X, Ren B, Li R, Ren X. Hui Z, et al. Front Immunol. 2015 Dec 17;6:633. doi: 10.3389/fimmu.2015.00633. eCollection 2015. Front Immunol. 2015. PMID: 26734004 Free PMC article.

8

Cytokine-induced killer cell therapy for the treatment of primary hepatocellular carcinoma subsequent to liver transplantation: A case report.

Li R, Yan F, Liu L, Li H, Ren B, Hui Z, Ren X. Li R, et al. Oncol Lett. 2016 Mar;11(3):1885-1888. doi: 10.3892/ol.2016.4109. Epub 2016 Jan 14. Oncol Lett. 2016. PMID: 26998094 Free PMC article.

9

Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.

Li R, Li H, Sun Q, Liu L, Zhang C, Ren X. Li R, et al. Mol Immunol. 2017 Jan;81:102-107. doi: 10.1016/j.molimm.2016.11.018. Epub 2016 Dec 5. Mol Immunol. 2017. PMID: 27930920

10

Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells.

Liu L, Zhang L, Yang L, Li H, Li R, Yu J, Yang L, Wei F, Yan C, Sun Q, Zhao H, Yang F, Jin H, Wang J, Wang SE, Ren X. Liu L, et al. Front Immunol. 2017 Apr 21;8:404. doi: 10.3389/fimmu.2017.00404. eCollection 2017. Front Immunol. 2017. PMID: 28484448 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters